Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share
-
Shares outstanding
-
266,212,950
-
Total 13F shares
-
18,088,058
-
Share change
-
+1,100,211
-
Total reported value
-
$569,233,000
-
Price per share
-
$31.47
-
Number of holders
-
32
-
Value change
-
+$34,029,483
-
Number of buys
-
12
-
Number of sells
-
20
Institutional Holders of Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL) as of Q1 2019
As of 31 Mar 2019,
Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL) was held by
32 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,088,058 shares.
The largest 10 holders included
Woodford Investment Management Ltd, Polygon Management Ltd., Cormorant Asset Management, LP, Alphabet Inc., Capital World Investors, PRICE T ROWE ASSOCIATES INC /MD/, Capital International Investors, MILLENNIUM MANAGEMENT LLC, Artal Group S.A., and MARSHALL WACE, LLP.
This page lists
32
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.